Advertisement

Collaboration › Details
Bruker–JPMorgan Chase: investor conference, 202201 supply service Bruker presents at JP Morgan Healthcare Conference 2022
![]() |
Period | 2022-01-10 |
![]() |
Partner, 1st | Bruker Corporation (Nasdaq: BRKR) |
Group | Bruker (Group) | |
Partner, 2nd | J.P. Morgan Securities LLC | |
![]() |
Product | J.P. Morgan 40th Annual Healthcare Conference 2022 DIGITAL |
Product 2 | analytical instrument | |
![]() |
Person | Laukien, Frank H. (Bruker 201204 President + CEO) |
Person 2 | Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel) | |
Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA.
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 40th annual J.P. Morgan Healthcare Conference, to be held virtually on January 10-13, 2022. Frank Laukien, Chairman, President & CEO and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 10th, 2022 at 9:00 AM Eastern Standard Time.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
Investor Contact:
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com
Record changed: 2022-01-15 |
Advertisement
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
More documents for Bruker (Group)
- [1] Bruker Corporation. (5/10/22). "Press Release: Bruker and TOFwerk Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets". Thun....
- [2] IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC....
- [3] Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA....
- [4] Bruker Corporation. (1/19/22). "Press Release: Bruker Acquires Prolab Instruments to Augment Multiomics Solutions". Billerica, MA....
- [5] PreOmics GmbH. (1/18/22). "Press Release: PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables". Munich....
- [6] Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [7] Bruker Corporation. (11/19/21). "Press Release: Bruker Announces Acquisition of Molecubes NV". Ghent....
- [8] Bico Group AB. (11/16/21). "Press Release: Cellenion Announces Co-marketing Agreement with Bruker to Deliver Advanced Solutions for Single Cell Mass Spectrometry-based Proteomics Analysis"....
- [9] PreOmics GmbH. (11/1/21). "Press Release: PreOmics Launches BeatBox at ASMS 2021 for High Throughput Tissue Homogenization"....
- [10] Bruker Corporation. (6/1/21). "Press Release: Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth". Billerica, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
» top